Culbertson A N & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Culbertson A N & Co's PFE Position: Q1 2026 in Review
Culbertson A N & Co reduced its Pfizer (PFE) stake by 32% in Q1 2026, selling an estimated $95.2K and leaving 7,582 shares worth $213K. The position accounts for 0.03% of the portfolio, ranked #129.
Culbertson A N & Co first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. The position peaked at $630K in Q3 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Culbertson A N & Co held 7,582 shares of Pfizer worth $213K as of Q1 2026.
- Culbertson A N & Co sold 3,575 Pfizer shares in Q1 2026, an estimated $95.2K.
- Pfizer made up 0.03% of Culbertson A N & Co's portfolio in Q1 2026, its #129 holding.
- Culbertson A N & Co first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
- Culbertson A N & Co's Pfizer position peaked at $630K in Q3 2024.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Culbertson A N & Co's 13F filing for Q1 2026, filed 12 May 2026.